THE PERMEABILITY GLOBULINS OF HUMAN SERUM AND THE BIOCHEMICAL MECHANISM OF HEREDITARY ANGIONEUROTIC EDEMA

The two permeability globulins, PF/dil.l and serum kallikrein,2 are apparently found in many, and possibly all, mammalian species.t They both exist in an inactive forrn in serum but can be activated by a number of the same procedures. Injection of either the activated form of PF/dil. or serum kallikrein into the appropriate animal will yield evidence of increased vascular permeabiiity. Both the permeability globulins are enzymes, splitting TAMe (p-toluene sulfonyl Larginine methyl ester) . In addition, they are both inhibitable by soybean trypsin inhibitor and by di-isopropylphosphofluoridate ( D F P ) , but not by ovomucoid. Because of these many similarities, a number of investigators suggested that these two permeability globulins are actually the sarne substance which happened to be given different names. Recent work, however, from our laboretory, which we will briefly describe, has clearly established that PF/ dil. and serum kallikrein exist in human qerurn as two distinct f a c t o r ~ . ~ ~ In addition, we wish to review the work, indicating the possible implication of these globulins in the biochemical mechanism of the genetically determined disease, hereditary angioneurotic edema.

[1]  Kagen Lj SOME BIOCHEMICAL AND PHYSICAL PROPERTIES OF THE HUMAN PERMEABILITY GLOBULINS. , 1964 .

[2]  O. Ratnoff,et al.  COMPLEMENT AS A MEDIATOR OF INFLAMMATION , 1963, The Journal of experimental medicine.

[3]  J. Leddy,et al.  THE PRESENCE OF TWO PERMEABILITY GLOBULINS IN HUMAN SERUM. , 1963, The Journal of clinical investigation.

[4]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[5]  G. E. Davies,et al.  Guinea Pig Kallikrein System , 1963, Nature.

[6]  J. Leddy,et al.  Isolation of Two Permeability Globulins from Human Serum , 1963, Nature.

[7]  J. Margolis THE INTERRELATIONSHIP OF COAGULATION OF PLASMA AND RELEASE OF PEPTIDES , 1963, Annals of the New York Academy of Sciences.

[8]  I. Trautschold,et al.  KALLIKREIN, KALLIDIN, KALLIKREIN INHIBITORS , 1963, Annals of the New York Academy of Sciences.

[9]  A. A. Miles,et al.  Globulin Permeability Factors without Kininogenase Activity , 1962, Nature.

[10]  E. Becker,et al.  Hereditary angioneurotic edema: II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein , 1962 .

[11]  N. S. Landerman Hereditary angioneurotic edema. I. Case reports and review of the literature. , 1962, The Journal of allergy.

[12]  O. Ratnoff,et al.  Role of Hageman Factor in the Activation of Vasodilator Activity in Human Plasma , 1961, Nature.

[13]  J. Pensky,et al.  Partial purification of a serum inhibitor of C'1-esterase. , 1961, The Journal of biological chemistry.

[14]  J. Pierce,et al.  Action of the Kallikreins on Synthetic Ester Substrates , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[15]  I. Lepow,et al.  Assay and Properties of Serum Inhibitor of C'1-Esterase∗ , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[16]  J. Margolis Hagerman factor and capillary permeability. , 1959, The Australian journal of experimental biology and medical science.

[17]  P. Mill,et al.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. VI. Isolation and properties of permeability factor and its inhibitor in human plasma. , 1958, British journal of experimental pathology.

[18]  O. Ratnoff,et al.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.

[19]  A. A. Miles,et al.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum. , 1955, British journal of experimental pathology.

[20]  D. Mittelman,et al.  A System for the Separation of the Components of Human Blood: Quantitative Procedures for the Separation of the Protein Components of Human Plasma1a,b,c , 1950 .